Corbus Pharmaceuticals Updates Presentation on CRB-701 and CRB-913
The presentation highlights CRB-701 registrational progress in OPSCC and positive Phase 1b CRB-913 obesity results.
The presentation highlights CRB-701 registrational progress in OPSCC and positive Phase 1b CRB-913 obesity results.